InMode to Present at the 25th Annual Needham Growth Conference
Get Alerts INMD Hot Sheet
Join SI Premium – FREE
YOKNEAM, Israel, Jan. 3, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chairman and Chief Executive Officer, Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present virtually at the 25th Annual Needham Growth Conference on Jan. 12, 2023.

The fireside chat, moderated by Mike Matson, Senior Research Analyst, is scheduled for 10:15 am Eastern Time on Thursday, Jan. 12 and will be webcast from InMode's Investor Relations website at https://inmodemd.com/investors/. InMode will also hold one-on-one investor meetings in person on Wednesday, Jan. 11 and virtual meetings on Thursday, Jan. 12. To schedule a meeting, please contact your Needham representative.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
Investor Relations Contact:Miri Segal-SchariaMS-IR LLC[email protected] + 917-607-8654
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-the-25th-annual-needham-growth-conference-301708515.html
SOURCE InMode Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FLAGSTAR BANK REPORTS SECOND QUARTER 2026 NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.06 PER DILUTED SHARE AND ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.05 PER DILUTED SHA
- Shanghai Electric showcases embodied intelligence robot matrix and AI-native smart factory solutions at WAIC 2026
- Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share